Recent Press Releases

New Transdermal Release Liner Helps Overcome Challenges with Difficult Formulations

ST. PAUL, MN – Feb. 8, 2016 – As patient preference and compliance are becoming increasingly important, transdermal patches are a great alternative for those who struggle with swallowing...

Spero Therapeutics Announces $30 Million Series B Preferred Financing

Funding Supports Development of Novel Therapies To Treat Gram-Negative Bacterial Infections CAMBRIDGE, Massachusetts, February 2, 2016 – Spero Therapeutics, a biopharmaceutical company founded...

Enable Injections and Flex Partner for Production of Wearable High Volume Injectors

Cincinnati, OH – February 3, 2016 – Enable Injections Inc., the developer and manufacturer of wearable medical devices thatenable easy patient self-administration of high volume...

Matinas BioPharma Receives FDA Clearance to Initiate Phase 1 Clinical Study of MAT2501 for the Treatment of Non-Tuberculous Mycobacterium Infections

BEDMINSTER, N.J., Feb. 01, 2016 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc.(OTCQB:MTNB), a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective...

Dr. Reddy's Laboratories Ltd. Receives FDA Approval for ZEMBRACE™SymTouch™ (sumatriptan succinate) Injection for the Acute Treatment of Migraines in Adults

HYDERABAD, India & PRINCETON, N.J.--()--Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that the U.S. Food and Drug Administration (FDA) has...

Intersect ENT Announces NUB Status 1 Designation for PROPEL Sinus Implant in Germany

Decision Represents Early Step in Building the Company's Foundation Internationally MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the...

Avanir Pharmaceuticals Announces FDA Approval of ONZETRATM XsailTM (AVP-825) for the Acute Treatment of Migraine in Adults

--ONZETRA Xsail is the first breath-powered intranasal medication delivery system for the acute treatment of migraine-- ALISO VIEJO, Calif., January 28, 2016 -- Avanir Pharmaceuticals, Inc. today...

Avanir Pharmaceuticals Announces FDA Approval of ONZETRATM XsailTM (AVP-825) for the Acute Treatment of Migraine in Adults

--ONZETRA Xsail is the first breath-powered intranasal medication delivery system for the acute treatment of migraine-- ALISO VIEJO, Calif., January 28, 2016 -- Avanir Pharmaceuticals, Inc. today...

Aprecia Pharmaceuticals Set to Advance 3D Printed Drug Pipeline with Completion of $35 Million Financing Led by Deerfield Management

LANGHORNE, Pa., Jan. 27, 2016 /PRNewswire/ -- Aprecia Pharmaceuticals Company, Inc., an emerging pharmaceutical company specializing in three-dimensionally printed (3DP) prescription medicine, today...

MERCATOR MEDSYSTEMS ANNOUNCES FIRST PATIENT TREATED IN CRITICAL LIMB ISCHEMIA TRIAL

Emeryville, CA., Jan. 21, 2016 -- Mercator MedSystems, Inc., has announced their first patient enrollment from Bad Krozingen, Germany, in the company's LIMBO-PTA clinical trial. This trial...

Nanoparticles combine photodynamic and molecular therapies against pancreatic cancer

Novel drug-delivery system cuts off common treatment escape pathways in animal models A nanoparticle drug-delivery system that combines two complementary types of anticancer treatment could improve...

Amatsigroup Acquires Q-Biologicals and Strengthens Its Offering for International Pharmaceutical Groups

January 25, 2016 07:33 AM Eastern Standard Time TOULOUSE, France--()--Amatsigroup, the leading French provider of services for the development of human and veterinary pharmaceutical...

West and Noble Collaborate to Improve Patient Education and Training for Self-Injection Systems

Presentation at Drug Delivery Partnerships 2016 will offer best practices for effective patient onboarding with wearable self-injection systems EXTON, Pa., Jan. 20, 2016 /PRNewswire/ -- West...

Ensysce Biosciences Inc. and Signature Therapeutics Inc. Merger

January 19, 2016 08:00 AM Eastern Standard Time SAN DIEGO, Calif.--()--Ensysce Biosciences and Signature Therapeutics are pleased to announce completion of a formal merger on Dec....

Svelte Medical Systems Announces European Launch of SLENDER IDS

The World's First Drug-Eluting Coronary Stent-on-a-Wire Integrated Delivery System Downsizes Catheters, Facilitates Transradial Intervention (TRI) and Maximizes Procedural Efficiency January 19,...

Using light for targeted drug delivery could help fight tumors, local infections

PUBLIC RELEASE: 20-JAN-2016 AMERICAN CHEMICAL SOCIETY Some drug regimens, such as those designed to eliminate tumors, are notorious for nasty side effects. Unwanted symptoms are often the result of...

Medicines360 and Camargo Pharmaceutical Gain FDA Approval for Intrauterine Contraceptive Device

Camargo Pharmaceutical Services, the most experienced global strategist in the drug development industry specializing in the 505(b)(2) approval pathway, has helped Medicines360 gain FDA approval for...

Catalent Biologics Announces Research Collaboration with Roche on SMARTag™ Technology

Collaboration focuses on development of novel molecules using SMARTag technology to couple different therapeutic modalities Roche will have option for commercial licenses to develop such...

Takeda and enGene Establish Strategic Alliance to Develop Novel Therapeutics for Gastrointestinal Diseases

OSAKA, Japan & MONTREAL--(BUSINESS WIRE)--Takeda Pharmaceutical Company Ltd. (TOKYO:4502) and enGene, Inc. today announced a strategic alliance to discover, develop and commercialize novel...

No More Needles at the Dentist – Just a Tiny Electric Current Instead

Research reveals a new way to administer anesthetic in the mouth If you're scared of the dentist's needles you're not alone – but new research means you might not have to put off that...